Literature DB >> 28064221

Wound Healing Delay in the ZDSD Rat.

Mark A Suckow1, Troy A Gobbett2, Richard G Peterson2.   

Abstract

Animal models of diabetic delayed wound healing are essential to the development of strategies to improve clinical approaches for human patients. The Zucker diabetic Sprague Dawley (ZDSD) rat has proved to be an accurate model of diet-induced obesity and diabetes and we evaluated the utility of the ZDSD rat as a model for delayed wound healing associated with diabetes and obesity. Groups of ZDSD and Sprague Dawley (SD) rats were placed on a diabetogenic diet and evaluated two weeks later for hyperglycemia, as a sign of diabetes. Rats with blood glucose levels of >300 mg/dl were considered diabetic and those with blood glucose of <180 mg/dl were considered non-diabetic. All SD rats were non-diabetic. A full-thickness excisional skin wound was created in anesthetized rats using a punch biopsy and wound diameter measured on days 1, 4, 7, 9 and 11. Blood glucose levels and body weights were measured periodically before and after wounding. Diabetic ZDSD rats had significantly greater blood glucose levels than non-diabetic ZDSD and SD rats within 10 days of being placed on the diabetogenic diet. Furthermore, diabetic ZDSD rats initially weighed more than non-diabetic ZDSD and SD rats, however, by the end of the study there was no significant difference in body weight between the ZDSD groups. By day nine, wounds in ZDSD rats were significantly larger than those in SD rats and this persisted until the end of the study at day fourteen. Wounds from all groups were characterized histologically by abundant fibroblast cells, collagen deposition and macrophages. These results demonstrate delayed wound healing in both diabetic and non-diabetic ZDSD rats and suggest that obesity or metabolic syndrome are important factors in wound healing delay. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Diabetes; obesity; rat; wound healing; zucker diabetic sprague dawley

Mesh:

Substances:

Year:  2017        PMID: 28064221      PMCID: PMC5354148          DOI: 10.21873/invivo.11025

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  41 in total

Review 1.  Models for use in wound healing research: a survey focusing on in vitro and in vivo adult soft tissue.

Authors:  F Gottrup; M S Agren; T Karlsmark
Journal:  Wound Repair Regen       Date:  2000 Mar-Apr       Impact factor: 3.617

Review 2.  Choosing life or limb. Improving survival in the multi-complex diabetic foot patient.

Authors:  Fran Game
Journal:  Diabetes Metab Res Rev       Date:  2012-02       Impact factor: 4.876

3.  Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

Authors:  I Vareniuk; I A Pavlov; I G Obrosova
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

4.  The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.

Authors:  Viktor R Drel; Nazar Mashtalir; Olga Ilnytska; Jeho Shin; Fei Li; Valeriy V Lyzogubov; Irina G Obrosova
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

5.  Limitations of the db/db mouse in translational wound healing research: Is the NONcNZO10 polygenic mouse model superior?

Authors:  Robert C Fang; Zol B Kryger; Donald W Buck; Mauricio De la Garza; Robert D Galiano; Thomas A Mustoe
Journal:  Wound Repair Regen       Date:  2010-10-18       Impact factor: 3.617

6.  Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss.

Authors:  P Dandona; R Weinstock; K Thusu; E Abdel-Rahman; A Aljada; T Wadden
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

7.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.

Authors:  D D Stieritz; I A Holder
Journal:  J Infect Dis       Date:  1975-06       Impact factor: 5.226

8.  Diabetes-obesity syndromes in mice.

Authors:  D L Coleman
Journal:  Diabetes       Date:  1982       Impact factor: 9.461

9.  Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.

Authors:  Jian Liu; Adeline Divoux; Jiusong Sun; Jie Zhang; Karine Clément; Jonathan N Glickman; Galina K Sukhova; Paul J Wolters; Juan Du; Cem Z Gorgun; Alessandro Doria; Peter Libby; Richard S Blumberg; Barbara B Kahn; Gökhan S Hotamisligil; Guo-Ping Shi
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

10.  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

Authors: 
Journal:  Lancet       Date:  2016-04-06       Impact factor: 79.321

View more
  4 in total

1.  Role of bone morphogenic protein-4 in gestational diabetes mellitus-related hypertension.

Authors:  Benshuo Cai; Juan Du
Journal:  Exp Ther Med       Date:  2021-05-13       Impact factor: 2.447

Review 2.  Clinically relevant experimental rodent models of diabetic foot ulcer.

Authors:  Vikrant Rai; Rebecca Moellmer; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2022-01-28       Impact factor: 3.396

3.  The ZDSD rat: a novel model of diabetic nephropathy.

Authors:  Richard G Peterson; Charles Van Jackson; Karen M Zimmerman
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

Review 4.  Zucker Diabetic-Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model.

Authors:  Andrea N Wang; Joselia Carlos; Graham M Fraser; John J McGuire
Journal:  Exp Physiol       Date:  2022-03-08       Impact factor: 2.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.